This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Neurology  • Cardiovascular System  • Diagnosis  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Young and colleagues¹ reported the lack of utility of MPI for predicting myocardial events in the DIAD study. However, the article contained information that suggests a simpler and possibly more effective means of predicting cardiovascular events.

In Table 5, the age- and sex-adjusted hazard ratio for the lowest quartile of cardiac autonomic dysfunction was 4.33 (95% confidence interval, 2.14-8.75; P < .001). A previous article from this group² reported that an autonomic function test that measures the Valsalva ratio (which incorporates cardiac parasympathetic and sympathetic nervous system activity³) was a strong predictor of myocardial ischemia (which may be silent). The study by Young et al reported results of change in heart rate from lying to standing, indicating that the presence of cardiac autonomic dysfunction had one of the highest hazard ratios associated with the primary events, greater than many of the other clinical factors. In addition, . . . [Full Text of this Article]

Aaron I. Vinik, MD, PhD
vinikai@evms.edu
Department of Medicine
Eastern Virginia Medical School
Norfolk

Raelene E. Maser, PhD
University of Delaware
Newark

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;301():1547-1555.
FULL TEXT  

RELATED LETTERS

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

JAMA. ;302():735-735.
FULL TEXT  

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes

JAMA. ;302():736-736.
FULL TEXT  

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes--Reply
and
JAMA. ;302():736-737.
FULL TEXT